Ajooni Biotech Limited (AJOONI) — Cash Flow-to-Debt Ratio
Ajooni Biotech Limited (AJOONI) has a Cash Flow-to-Debt Ratio of 0.95x as of September 2025, meaning its operating cash flow of Rs135.46 Million could theoretically repay 1% of its total liabilities (Rs143.18 Million) in one year. Check AJOONI capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Ajooni Biotech Limited Cash Flow-to-Debt Ratio (2013–2026)
Historical debt coverage capacity for Ajooni Biotech Limited across 14 annual periods. Also explore Ajooni Biotech Limited balance sheet assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Ajooni Biotech Limited (2013–2026)
Year-by-year debt coverage analysis for Ajooni Biotech Limited. For market capitalisation and broader financial context, see AJOONI market cap overview.
| Year | CF-to-Debt Ratio | Operating CF (INR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2026 | -0.18x | Rs-52.03 Million | Rs291.74 Million | ▲ +93.0% |
| 2025 | -2.54x | Rs-177.37 Million | Rs69.72 Million | ▼ -209.7% |
| 2024 | -0.82x | Rs-39.52 Million | Rs48.12 Million | ▼ -151.2% |
| 2023 | -0.33x | Rs-55.79 Million | Rs170.62 Million | ▼ -212.2% |
| 2022 | 0.29x | Rs36.84 Million | Rs126.35 Million | ▲ +212.2% |
| 2021 | 0.09x | Rs11.56 Million | Rs123.76 Million | ▲ +115.3% |
| 2020 | -0.61x | Rs-43.85 Million | Rs71.76 Million | ▲ +24.4% |
| 2019 | -0.81x | Rs-49.19 Million | Rs60.85 Million | ▼ -13265151475.7% |
| 2018 | 0.00x | Rs-0.51 | Rs83.70 Million | ▲ +100.0% |
| 2017 | -0.06x | Rs-6.69 Million | Rs118.86 Million | ▲ +82.6% |
| 2016 | -0.32x | Rs-6.15 Million | Rs19.06 Million | ▼ -330.1% |
| 2015 | 0.14x | Rs1.67 Million | Rs11.88 Million | ▲ +114.2% |
| 2014 | -0.99x | Rs-1.45 Million | Rs1.46 Million | ▲ +80.2% |
| 2013 | -5.00x | Rs-10.00K | Rs2.00K | — |